Latest Breaking News On - Robert molander - Page 2 : vimarsana.com

SciBase resolves on a directed issue of approximately SEK 33 million and a rights issue of approximately SEK 15 million

/PRNewswire/ The Board of Directors SciBase Holding AB (publ) ("SciBase" or the "Company") has today resolved on a capital raise totaling approximately SEK.

United statesSouth africaHong kongNew zealandRobert molanderViktor drvotaPia renaudinEric terhaerdtFredrik mattssonJesper hoilandTord lendauStefan hanssonMatt leavittAdvokatfirman schjSwedish companies registration officeNeither the company

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2022

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert molanderMichael owensAustralian patent officeAmerican association of pediatricsData monitoring committeeOrphan drug designationAmerican associationConnection studyAnnual general meetingChief commercial officerNasdaq stockholmSmall cap

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1

Message from the CEO IBT's vision is to become an internationally leading company in the development of pharmaceuticals in the areas of premature infants, gastrointestinal diseases and probiotics. We

United statesRobert molanderMichael owensAustralian patent officeAmerican association of pediatricsData monitoring committeeOrphan drug designationAmerican associationConnection studyAnnual general meetingChief commercial officerNasdaq stockholmSmall cap

Investegate |Infant Bacterial Therapeutics Announcements | Infant Bacterial Therapeutics: Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics

Investegate announcements from Infant Bacterial Therapeutics, Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics

Sten irweRobert molanderSebastian jahreskogJannis kitsakisPeter rothschildErik andersson annwall rothschildMargareta hagmanAnthon jahreskogNomination committeeSwedish companies registration office swSwedish companiesAudit committeeRemuneration committeeAnnual general meetingInfant bacterialInfant bacterial therapeutics

Infant Bacterial Therapeutics AB: Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics

Shareholders of Infant Bacterial Therapeutics AB (publ) are summoned to the Annual General Meeting on Wednesday, May 4, 2022. In light of the coronavirus, the Annual General Meeting is conducted through

Sten irweRobert molanderSebastian jahreskogJannis kitsakisPeter rothschildErik andersson annwall rothschildMargareta hagmanAnthon jahreskogNomination committeeSwedish companies registration office swSwedish companiesAudit committeeRemuneration committeeInfant bacterial therapeuticsAnnual general meetingEuroclear sweden